Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: a preferential benefit for squamous cell carcinoma
, , , , , , , und
03. Dez. 2020
Über diesen Artikel
Artikel-Kategorie: Research Article
Online veröffentlicht: 03. Dez. 2020
Seitenbereich: 66 - 76
Eingereicht: 21. Juli 2020
Akzeptiert: 06. Okt. 2020
DOI: https://doi.org/10.2478/raon-2020-0070
Schlüsselwörter
© 2021 Cuimeng Tian, Guimei Liu, Yongxiang Xu, Guangrong Xia, Tongmei Zhang, Jiaqiang Huang, Hui Jiang, Ji Ming Wang, Baolan Li, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Figure 1

Figure 2

Univariate analyses of the factors affecting overall survival (OS), loco-regional recurrence-free survival (LRFS) and distant metastasis-free survival (DMFS) of lung squamous cell carcinoma (LADC) patients (N = 194)
Characteristics | No. | OS | LRFS | DMFS | |||
---|---|---|---|---|---|---|---|
5-year OS, % | P | 5-year LRFS, % | P | 5-year DMFS, % | P | ||
0.071 | 0.085 | 0.139 | |||||
| 96 | 48.2 | 46.9 | 44.1 | |||
| 98 | 39.6 | 37.1 | 30.6 | |||
0.751 | 0.811 | 0.494 | |||||
| 139 | 43.6 | 41.6 | 34.5 | |||
| 55 | 45.0 | 42.8 | 41.3 | |||
0.001* | 0.001* | 0.006* | |||||
| 127 | 50.4 | 49.4 | 44.5 | |||
| 67 | 31.0 | 27.4 | 22.7 | |||
0.468 | 0.158 | 0.319 | |||||
| 178 | 44.1 | 42.3 | 36.5 | |||
| 16 | 41.7 | 38.5 | 37.5 | |||
0.032* | 0.020* | 0.001* | |||||
| 166 | 46.3 | 44.0 | 40.4 | |||
| 28 | 29.5 | 28.0 | 15.5 | |||
0.001* | 0.002* | 0.000* | |||||
| 46 | 60.9 | 58.3 | 58.8 | |||
| 62 | 37.9 | 38.8 | 37.8 | |||
| 86 | 38.7 | 35.4 | 22.5 | |||
0.000* | 0.000* | 0.000* | |||||
| 87 | 56.6 | 54.7 | 53.4 | |||
| 107 | 33.3 | 31.4 | 20.4 | |||
0.000* | 0.001* | 0.000* | |||||
| 80 | 54.8 | 52.7 | 51.8 | |||
| 114 | 35.7 | 34.0 | 26.9 | |||
0.001* | 0.002* | 0.001* | |||||
| 46 | 60.9 | 58.3 | 58.8 | |||
| 148 | 38.3 | 36.9 | 29.0 | |||
0.169 | 0.280 | 0.541 | |||||
| 24 | 34.4 | 36.5 | 37.5 | |||
| 170 | 44.9 | 43.0 | 36.6 | |||
0.948 | 0.723 | 0.440 | |||||
| 152 | 45.0 | 43.0 | 38.8 | |||
| 42 | 40.0 | 40.0 | 28.7 |
Multivariate analyses of the factors affecting overall survival (OS), loco-regional recurrence-free survival (LRFS) and distant metastasis-free survival (DMFS) of lung adenocarcinoma (LSCC) patients (N = 85)
Characteristics | OS | LRFS | DMFS | |||
---|---|---|---|---|---|---|
HR (95% CI) | P | HR(95% CI) | P | HR (95% CI) | P | |
0.789 | 0.823 | 0.563 | ||||
| 1 | 1 | 1 | |||
| 0.905(0.436–1.880) | 0.922(0.454–1.874) | 0.806(0.389–1.672) | |||
0.208 | 0.149 | 0.151 | ||||
| 1 | 1 | 1 | |||
| 1.436(0.817–2.522) | 1.524(0.860–2.701) | 1.522(0.858–2.699) | |||
0.257 | 0.296 | 0.664 | ||||
| 1 | 1 | 1 | |||
| 1.618(0.704–3.715) | 1.556(0.679–3.563) | 1.194(0.537–2.657) | |||
0.440 | 0.454 | 0.330 | ||||
| 1 | 1 | 1 | |||
| 1.322(0.650–2.689) | 1.308(0.648–2.643) | 1.428(0.697–2.925) | |||
0.922 | 0.963 | 0.813 | ||||
| 1 | 1 | 1 | |||
| 1.043(0.447–2.436) | 0.979(0.409–2.343) | 0.903(0.385–2.114) | |||
0.127 | 0.224 | 0.496 | ||||
| 1 | 1 | 1 | |||
| 0.523(0.227–1.202) | 0.595(0.258–1.374) | 0.751(0.328–1.715) | |||
0.017* | 0.006* | 0.013* | ||||
| 1 | 1 | 1 | |||
| 0.364(0.159–1.832) | 0.308(0.133–0.712) | 0.349(0.152–0.802) |
Univariate analyses of the factors affecting overall survival (OS), loco-regional recurrence-free survival (LRFS) and distant metastasis-free survival (DMFS) of lung adenocarcinoma (LSCC) patients (N = 85)
Characteristics | No | OS | LRFS | DMFS | |||
---|---|---|---|---|---|---|---|
5-year OS, % | P | 5-year LRFS, % | P | 5-year DMFS, % | P | ||
0.670 | 0.784 | 0.762 | |||||
| 7 | 42.9 | 42.9 | 42.9 | |||
| 78 | 43.2 | 39.1 | 41.3 | |||
0.362 | 0.617 | 0.447 | |||||
| 60 | 46.4 | 40.8 | 43.9 | |||
| 25 | 36.0 | 36.0 | 36.0 | |||
0.713 | 0.659 | 0.767 | |||||
| 18 | 55.6 | 44.4 | 50.0 | |||
| 67 | 39.6 | 37.8 | 39.0 | |||
0.283 | 0.375 | 0.498 | |||||
| 57 | 47.6 | 42.4 | 45.5 | |||
| 28 | 34.1 | 33.2 | 33.9 | |||
0.341 | 0.289 | 0.237 | |||||
| 56 | 46.4 | 44.1 | 47.1 | |||
| 29 | 37.0 | 30.3 | 31.8 | |||
0.625 | 0.596 | 0.882 | |||||
| 31 | 50.6 | 44.4 | 44.8 | |||
| 26 | 41.3 | 37.8 | 41.2 | |||
| 28 | 35.2 | 34.3 | 38.1 | |||
0.115 | 0.161 | 0.431 | |||||
| 45 | 49.2 | 45.2 | 46.1 | |||
| 40 | 36.7 | 34.1 | 36.1 | |||
0.152 | 0.154 | 0.265 | |||||
| 51 | 48.7 | 43.8 | 46.9 | |||
| 34 | 34.4 | 33.0 | 33.1 | |||
0.367 | 0.363 | 0.654 | |||||
| 31 | 50.6 | 44.4 | 44.8 | |||
| 54 | 38.9 | 36.9 | 39.7 | |||
0.316 | 0.371 | 0.525 | |||||
| 13 | 30.8 | 30.8 | 30.8 | |||
| 72 | 45.3 | 40.9 | 43.5 | |||
0.026* | 0.008** | 0.018* | |||||
| 66 | 37.7 | 32.5 | 35.3 | |||
| 19 | 63.2 | 63.2 | 63.2 |
Multivariate analyses of the factors affecting overall survival (OS), loco-regional recurrence-free survival (LRFS) and distant metastasis-free survival (DMFS) of lung squamous cell carcinoma (LADC) patients (N = 194)
Characteristics | OS | LRFS | DMFS | |||
---|---|---|---|---|---|---|
HR (95% CI) | P | HR(95% CI) | P | HR (95% CI) | P | |
0.000* | 0.000* | 0.005* | ||||
| 1 | 1 | 1 | |||
| 2.172(1.471–3.207) | 2.098(1.421–3.099) | 1.739(1.181–2.560) | |||
0.074 | 0.156 | 0.002* | ||||
| 1 | 1 | 1 | |||
| 1.560(0.958–2.542) | 1.428(0.873–2.337) | 2.120(1.308–3.435) | |||
0.255 | 0.234 | 0.134 | ||||
| 1 | 1 | 1 | |||
| 1.403(0.783–2.512) | 1.441(0.789–2.632) | 1.624(0.861–3.062) | |||
0.392 | 0.435 | 0.471 | ||||
| 1 | 1 | 1 | |||
| 1.313(0.704–2.447) | 1.291(0.680–2.452) | 1.283(0.651–2.528) | |||
0.015* | 0.046* | 0.141 | ||||
| 1 | 1 | 1 | |||
| 2.065(1.148–3.714) | 1.818(1.010–3.272) | 1.565(0.863–2.839) | |||
0.004* | 0.031* | 0.047* | ||||
| 1 | 1 | 1 | |||
| 0.417(0.230–0.757) | 0.524(0.291–0.942) | 0.554(0.310–0.992) | |||
0.759 | 0.737 | 0.444 | ||||
| 1 | 1 | 1 | |||
| 1.074(0.680–1.697) | 0.924(0.584–1.463) | 1.196(0.756–1.891) |
Patient characteristics
Characteristic | LADC ( N = 194 ) | LSCC ( N = 85 ) | ||||||
---|---|---|---|---|---|---|---|---|
Total, n (%) | Non-PORT, n (%) | PORT, n (%) | P | Total, n (%) | Non-PORT, n (%) | PORT, n (%) | P | |
0.262 | 0.593 | |||||||
| 96(49.5) | 72(47.4) | 24(57.1) | 7(8.2) | 6(9.1) | 1(5.3) | ||
| 98(50.5) | 80(52.6) | 18(42.9) | 78(91.8) | 60(90.9) | 18(94.7) | ||
0.058 | 0.814 | |||||||
| 139(71.6) | 104(68.4) | 35(83.3) | 60(70.6) | 47(71.2) | 13(68.4) | ||
| 55(28.4) | 48(31.6) | 7(16.7) | 25(29.4) | 19(28.8) | 6(31.6) | ||
0.199 | 0.058 | |||||||
| 127(65.5) | 96(63.2) | 31(73.8) | 18(21.2) | 11(16.7) | 7(36.8) | ||
| 67(34.5) | 56(36.8) | 11(26.2) | 67(78.8) | 55(83.3) | 12(63.2) | ||
0.028 | 0.211 | |||||||
| 178(91.8) | 136(89.5) | 42(100) | 57(84.0) | 42(63.6) | 15(78.9) | ||
| 16(8.2) | 16(10.5) | 0(0.0) | 28(16.0) | 24(36.4) | 4(21.1) | ||
0.044 | 0.167 | |||||||
| 166(85.6) | 126(82.9) | 40(95.2) | 56(65.9) | 46(69.7) | 10(52.6) | ||
| 28(14.4) | 26(17.1) | 2(4.8) | 29(34.1) | 20(30.3) | 9(47.4) | ||
0.228 | 0.989 | |||||||
| 46(23.7) | 38(25.0) | 8(19.0) | 31(36.5) | 24(36.4) | 7(36.8) | ||
| 62(32.0) | 44(28.9) | 18(42.9) | 26(30.6) | 20(30.3) | 64(31.6) | ||
| 86(44.3) | 70(46.1) | 16(38.1) | 28(32.9) | 22(33.3) | 6(31.6) | ||
0.090 | 0.581 | |||||||
| 87(44.8) | 73(48.0) | 14(33.3) | 45(52.9) | 36 (54.5) | 9(47.4) | ||
| 107(55.2) | 79(52.0) | 28(66.7) | 40(47.1) | 30(45.5) | 10(52.6) | ||
0.060 | 0.832 | |||||||
| 80(41.2) | 68(44.7) | 12(28.6) | 51(60.0) | 40(60.6) | 11(57.9) | ||
| 114(58.8) | 84(55.3) | 30(71.4) | 34(40.0) | 26(39.4) | 8(42.1) | ||
0.422 | 0.970 | |||||||
| 46(23.7) | 38(25.0) | 8(19.0) | 31(36.5) | 24(36.4) | 7(36.8) | ||
| 148(76.3) | 114(75.0) | 34(81.0) | 54(63.5) | 42(63.6) | 12(63.2) | ||
0.026 | 0.512 | |||||||
| 24(12.4) | 23(15.1) | 1(2.4) | 13(15.3) | 11(16.7) | 2(10.5) | ||
| 170(87.6) | 129(84.9) | 41(97.6) | 72(84.7) | 55(83.3) | 17(89.5) |